Status:
COMPLETED
MK-0941 Multiple Dose Study in Japanese Patients With Type 2 Diabetes (MK-0941-011).
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Diabetes Mellitus, Non-Insulin-Dependent
Eligibility:
All Genders
20-65 years
Phase:
PHASE1
Brief Summary
The multiple dose study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of MK-0941 in Japanese patients with Type 2 Diabetes.
Eligibility Criteria
Inclusion
- Japanese Male or Female between 20 to 65 years of age
- Diagnosis of Type 2 Diabetes
- Patient being treated by diet and exercise alone
Exclusion
- Patient has a history of Type 1 Diabetes
- Patient is being treated with glaucoma medications
- Patient has donated blood or participated in another clinical study in the past 12 weeks
- Patient is a regular user of any illicit drugs or has a history of drug, including alcohol, abuse
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00754130
Start Date
September 1 2008
End Date
October 1 2008
Last Update
March 12 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.